2024 annual financial data
Jade Biosciences 2024 Operating margin
Jade Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -74,596,000 USD and net income was -69,628,000 USD.
Operating cash flow was -71,196,000 USD.
Get free Jade Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -74,596,000 USD
- Net income
- -69,628,000 USD
- Operating cash flow
- -71,196,000 USD